Publication | Closed Access

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

Cell TherapyTransplantationMarrow TransplantationMedicineStem Cell TransplantationHematologyImmunologyDonor Leukocyte InfusionsAutoimmunityRadiation OncologyImmunotherapyCell TransplantationGraft RejectionRecurrent Hematologic MalignanciesHealth Sciences